Influence of ultra-low dose Aprotinin on thoracic surgical operations: a prospective randomized trial.

about

Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion

P2860

Q24235627-F1B9826F-846D-415F-83F3-E0D6792D1680

P2860

Influence of ultra-low dose Aprotinin on thoracic surgical operations: a prospective randomized trial.

Item

http://www.wikidata.org/entity/Q36526980

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Influence of ultra-low dose Ap ...... prospective randomized trial.

@ast

Influence of ultra-low dose Ap ...... prospective randomized trial.

@en

type

Item

label

Influence of ultra-low dose Ap ...... prospective randomized trial.

@ast

Influence of ultra-low dose Ap ...... prospective randomized trial.

@en

prefLabel

Influence of ultra-low dose Ap ...... prospective randomized trial.

@ast

Influence of ultra-low dose Ap ...... prospective randomized trial.

@en

P1476

Influence of ultra-low dose Ap ...... prospective randomized trial.

@en

P2093

Dimitrios Dougenis

http://www.w3.org/2001/XMLSchema#string

Efrosini Sourgiadaki

http://www.w3.org/2001/XMLSchema#string

Efstratios Apostolakis

http://www.w3.org/2001/XMLSchema#string

Efstratios N Koletsis

http://www.w3.org/2001/XMLSchema#string

Helen Stamou-Kouki

http://www.w3.org/2001/XMLSchema#string

James Crockett

http://www.w3.org/2001/XMLSchema#string

Kriton Filos

http://www.w3.org/2001/XMLSchema#string

Nikolaos Panagopoulos

http://www.w3.org/2001/XMLSchema#string

P2860

Ultra-low dose aprotinin decreases transfusion requirements and is cost effective in coronary operations

Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: a systematic review and meta-analysis of randomized clinical trials

Aprotinin and the systemic inflammatory response after cardiopulmonary bypass.

Aprotinin: an update of its pharmacology and therapeutic use in open heart surgery and coronary artery bypass surgery.

Chest re-exploration for complications after lung surgery.

Optimal management of bleeding and transfusion in patients undergoing cardiac surgery.

Effect of aprotinin on need for blood transfusion after repeat open-heart surgery.

The potential role of aprotinin in the perioperative management of malignant tumors.

An anti-platelet-endothelial cell adhesion molecule-1 antibody inhibits leukocyte extravasation from mesenteric microvessels in vivo by blocking the passage through the basement membrane

Aprotinin. A review of its pharmacology and therapeutic efficacy in reducing blood loss associated with cardiac surgery.

P2888

1749-8090-3-14

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1749-8090-3-14

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2008-03-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5490169

http://www.w3.org/2001/XMLSchema#string

P6179

1015304186

http://www.w3.org/2001/XMLSchema#string

P698

18361800

http://www.w3.org/2001/XMLSchema#string

P932

2287179

http://www.w3.org/2001/XMLSchema#string

Influence of ultra-low dose Aprotinin on thoracic surgical operations: a prospective randomized trial.

about

P2860

P2860

Influence of ultra-low dose Aprotinin on thoracic surgical operations: a prospective randomized trial.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P577

P5875

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P577

P5875

P6179

P698

P932